The Australian Immunisation Handbook 9th Edition by Australian Government, Department of Health and Ageing, National Health and Medical Research Council 1741864844 9781741864847

The Australian Immunisation Handbook 9th Edition by Australian Government, Department of Health and Ageing, National Health and Medical Research Council – Ebook PDF Instant Download/Delivery: 1741864844, 9781741864847

Full download The Australian Immunisation Handbook 9th Edition after payment

Product details:

ISBN 10: 1741864844 

ISBN 13: 9781741864847

Author: Australian Government, Department of Health and Ageing, National Health and Medical Research Council

“The 9th edition of The Australian immunisation handbook was prepared by the Australian Technical Advisory Group on Immunisation of the Australian Government Department of Health and Ageing.”–Pref.
Includes index.
The 9th edition introduces new vaccines, changes to the schedules, changes to recommendations and procedures regarding the administration of vaccines, and changes to the presentation of the Handbook.
Title on card: National immunisation program schedule.
Also available electronically via the Internet.

Table of contents:

1.1 What’s new?
1.2 An overview of vaccination – preface to Chapters 1.3–1.5
1.3.2 Effective cold chain: transport, storage and handling of vaccines
1.3.3 Valid consent
1.3.4 Pre-vaccination screening
Table 1.3.4: False contraindications to vaccination
1.4.2 Equipment for vaccination
1.4.3 Route of administration
1.4.4 Preparation for vaccine administration
1.4.5 Vaccine injection techniques
Table 1.4.2: Recommended needle size, length and angle for administering vaccines
1.4.7 Positioning for vaccination
1.4.8 Identifying the injection site
1.4.9 Administering multiple vaccine injections at the same visit
1.5.2 Adverse events following immunisation
Table 1.5.3: Contact details for notification of AEFI
1.5.4 The Australian Childhood Immunisation Register
2.1 Vaccination for Aboriginal and Torres Strait Islander people
2.2 Vaccination for international travel
2.3.2 Vaccination of women planning pregnancy, pregnant or breastfeeding women, and preterm infants
2.3.3 Vaccination of individuals with impaired immunity due to disease or treatment
2.3.5 Vaccination of patients following receipt of other blood products including blood transfusions
2.3.8 Vaccination of those at occupational risk
2.3.11 Vaccination of men who have sex with men
2.3.12 Vaccination of injecting drug users
3.1 Australian bat lyssavirus infection and rabies
3.2 Cholera
3.3 Diphtheria
3.4 Haemophilus influenzae type b (hib)
3.5 Hepatitis A
3.6 Hepatitis B
3.7 Human papillomavirus
3.8 Immunoglobulin preparations
3.9 Influenza
3.10 Japanese encephalitis
3.11 Measles
3.12 Meningococcal disease
3.13 Mumps
3.14 Pertussis
3.15 Pneumococcal disease
3.16 Poliomyelitis
3.17 Q fever
3.18 Rotavirus
3.19 Rubella
3.20 Smallpox
3.21 Tetanus
3.22 Tuberculosis
3.23 Typhoid
3.24 Varicella
3.25 Yellow fever
3.26 Zoster (herpes zoster)
Appendix 1: Contact details for Australian, State and Territory Government health authorities and communicable disease control
Appendix 2: Handbook development
Appendix 3: Products registered in Australia but not currently available
Appendix 4: Components of vaccines used in the National Immunisation Program
Appendix 5: Commonly asked questions about vaccination
Appendix 6: Definitions of adverse events following immunisation
Appendix 7: Glossary of technical terms
Appendix 8: List of commonly used abbreviations
Appendix 9: Dates when vaccines became available in Australia
Appendix 10: Summary table – procedures for a vaccination encounter
Table 1.3.1: Pre-vaccination screening checklist
Table 1.3.2: Responses to relevant conditions or circumstances identified by the pre-vaccination screening checklist
Table 1.3.3: Live attenuated parenteral and oral vaccines
Table 1.3.5: Number of vaccine doses that should have been administered by the current age of the child
Table 1.3.6: Minimum dose intervals for NIP vaccines for children <8 years of age
Table 1.3.7: Minimum age for the first dose of vaccine in exceptional circumstances
Table 1.3.8: Recommendations for Hib catch-up vaccination for children <5 years of age when doses have been delayed or missed
Table 1.3.9: Recommendations for pneumococcal catch-up vaccination for low-risk children <2 years of age
Table 1.3.10: Recommendations for pneumococcal catch-up vaccination for Indigenous children <2 years of age in NT, QLD, SA and WA
Table 1.3.11: Recommendations for pneumococcal catch-up vaccination for children ≤5 years of age with underlying medical conditions
Table 1.3.12: Catch-up schedules for individuals ≥8 years of age
Table 1.4.1: Route of administration for vaccines commonly used in Australia
Table 1.5.1: Clinical features which may assist differentiation between a vasovagal episode and anaphylaxis
Table 1.5.2: Doses of intramuscular 1:1000 adrenaline for anaphylaxis
Table 2.2.1: Dose and routes of administration of commonly used vaccines in adult travellers
Table 2.2.2: Recommended lower age limits of travel vaccines for children
Table 2.3.1: Vaccinations in pregnancy
Table 2.3.2: Recommendations for vaccinations for solid organ transplant (SOT) recipients
Table 2.3.3: Post-transplantation vaccination schedules for haematopoietic stem cell transplant recipients
Table 2.3.4: Immunological categories based on age-specific CD4 counts
Table 2.3.5: Recommended intervals between either immunoglobulins or blood products and MMR, MMRV or varicella vaccination
Table 2.3.6: Recommended vaccinations for those at risk of occupationally acquired vaccine-preventable diseases
Table 3.1.1: Summary of Australian bat lyssavirus and rabies post-exposure treatment
Table 3.5.1: Recommended dosages and schedules for hepatitis A vaccines
Table 3.5.2: Recommended doses of normal human immunoglobulin for contacts of hepatitis A cases
Table 3.6.1: Hepatitis B and combination vaccination schedules
Table 3.6.2: Accelerated hepatitis B vaccination schedules
Table 3.6.3: Post-exposure prophylaxis for hepatitis B
Table 3.9.1: Recommended doses of influenza vaccine
Table 3.11.1: Management of measles exposure
Table 3.12.1: Early clinical management of suspected meningococcal disease
Table 3.14.1: Antimicrobial therapy and chemoprophylaxis for pertussis
Table 3.15.1: Pneumococcal vaccination schedule for children ≤9 years
Table 3.15.2: Underlying medical conditions predisposing children to IPD
Table 3.15.3: Revaccination with 23vPPV for people ≥10 years
Table 3.17.1: Interpretation and action for Q fever serological and skin test results
Table 3.18.1: Age limits for dosing of oral rotavirus vaccines
Table 3.21.1: Guide to tetanus prophylaxis in wound management
Table 3.24.1: Varicella vaccination recommendations
Table 3.24.2: Zoster immunoglobulin-VF dose based on weight
Table 3.25.1: Yellow fever endemic countries

People also search:

the australian immunisation handbook 10th edition

australian immunisation handbook 9th edition

the australian immunisation handbook pdf

the australian immunisation handbook 10th edition 2013

Tags: Australian Government, Department of Health and Ageing, Immunisation